ArticleFrontiers in pediatrics2025
Clinical outcomes and risk factors in pediatric patients with solitary functioning kidney: a comparative analysis of congenital and acquired etiologies.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clear cell sarcoma of the kidney with inferior vena cava tumor thrombus in a pediatric patient: a case report.The Canadian journal of urology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aims to assess the clinical outcomes and kidney function in pediatric patients with a solitary functioning kidney (SFK) due to various causes. It focuses on evaluating the glomerular filtration rate (GFR) across five groups: renal agenesis, multicystic dysplastic kidney (MCDK), atrophic kidney, hypoplastic kidney, and patients who underwent nephrectomy due to bleeding, stones, infection, or tumor without having progressed to renal failure. Methods: A retrospective chart review was conducted on single kidneys of 396 patients seen at the pediatric nephrology clinic from January 2011 to June 2024. Descriptive statistics were used to summarize the data, with chi-square tests employed for categorical variables and Results: Baseline and final GFR values showed significant differences between the groups in the pre- and post-tests. The MCDK group had significantly lower GFR than the renal agenesis group and the remaining etiologies. Albumin levels were decreased in MCDK patients, whereas neutrophil levels were elevated in patients with renal agenesis. Hypertension or proteinuric activity did not exhibit significant variations in the frequency across these groups. Discussion: This study highlights the importance of a personalized management approach for pediatric patients with an SFK, specifically those with MCDK, who are more likely experience early loss of kidney function. Minimizing the risks and improving the outcomes would require a routine, topical course of monitoring, along with appropriate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.